iBio Highlights Data from a Non-human Primate Study Supporting IBIO-610’s Potential to Preserve Muscle in Combination with GLP-1 Therapy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
| IBIO, Inc. (NASDAQ: IBIO) | Delayed: 0.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.77 | 52 Week High | $0.80 | |||
| Open | $0.77 | 52 Week Low | $0.34 | |||
| Day High | $0.77 | P/E | N/A | |||
| Day Low | $0.77 | EPS | $-0.08 | |||
| Volume | 8 | |||||
